ANALYSIS OF THE BUDGET IMPACT OF SECUKINUMAB USE VERSUS ANTI-TNF AGENTS IN ANKYLOSING SPONDYLITIS PATIENTS

被引:0
|
作者
Romero Prada, M. E. [1 ]
Roa, Cardenas N. C. [1 ]
Serrano, G. Y. [1 ]
Huerfano, L. M. [1 ]
机构
[1] Salutia Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMS11
引用
收藏
页码:A937 / A937
页数:1
相关论文
共 50 条
  • [31] Superior outcomes for military ankylosing spondylitis patients treated with anti-TNF
    Rees, Jonathan D.
    Bennett, A. N.
    Harris, D.
    Jones, T.
    JOURNAL OF THE ROYAL ARMY MEDICAL CORPS, 2014, 160 (04) : 310 - 313
  • [32] The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
    Murat Karkucak
    Erhan Capkin
    Ahmet Alver
    Ayse Akyuz
    Abdulkadir Kiris
    Emel Ak
    Murat Topbas
    Mehmet Tosun
    Clinical Rheumatology, 2010, 29 : 303 - 307
  • [33] WORKING STATUS IN PATIENTS WITH ANKYLOSING SPONDYLITIS RECEIVING ANTI-TNF THERAPY
    Verstappen, Suzanne M. M.
    Watson, Kath D.
    McGrother, Katie
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2009, 48 : I111 - I111
  • [34] Patients' experience of anti-TNF therapy for ankylosing spondylitis: A qualitative study
    Strawson, J.
    Marshall, N. J.
    Kay, L. J.
    RHEUMATOLOGY, 2006, 45 : I64 - I64
  • [35] The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
    Karkucak, Murat
    Capkin, Erhan
    Alver, Ahmet
    Akyuz, Ayse
    Kiris, Abdulkadir
    Ak, Emel
    Topbas, Murat
    Tosun, Mehmet
    CLINICAL RHEUMATOLOGY, 2010, 29 (03) : 303 - 307
  • [36] PARADOXICAL PSORIATIC EFFECTS OF ANTI-TNF THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Zlnay, M.
    Salkova, M.
    Oetterova, M.
    Rovensky, J.
    Rybar, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 274 - 275
  • [37] A cost efficacy analysis on Anti-TNF therapy in ankylosing spondylitis.
    Singh, G
    Tandon, N
    Bala, M
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S613 - S613
  • [38] Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-TNF agents infliximab and etanercept
    Braun, J
    Baraliakos, X
    Listing, J
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 64 - 64
  • [39] COMPARING COSTS OF ANTI-TNF THERAPY BY ADMINSTRATION ROUTE FOR PATIENTS WITH ANKYLOSING SPONDYLITIS AND RHEUMATOID ARTHRITIS IN FRANCE IN 2012: A BUDGET IMPACT MODEL
    Chevreul, K.
    Bourguignon, S.
    Granados, D.
    VALUE IN HEALTH, 2012, 15 (07) : A440 - A441
  • [40] BASDAI ASSESSMENT FOR ANTI-TNF THERAPY IN ANKYLOSING SPONDYLITIS
    Mackenzie, S.
    Miah, S.
    Kane, D.
    John, H.
    Roger, S.
    RHEUMATOLOGY, 2004, 43 : 124 - 124